In clinical practice three tests are used to detect antiphospholipid antibodies (aPL), the serological hallmark of antiphospholipid syndrome (APS), a condition characterised particularly by vascular thrombosis (VT) and pregnancy morbidity (PM) [1]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.